Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease

被引:128
|
作者
Karalliedde, Janaka [1 ]
Gnudi, Luigi [1 ]
机构
[1] Kings Coll London, Sch Life Sci & Med, Div Cardiovasc, Unit Metab Med,Dept Diabet & Endocrinol, London WC2R 2LS, England
关键词
diabetes; insulin resistance; kidney disease; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; MOLECULAR-MECHANISMS; METABOLIC-DISORDERS; BETA EXPRESSION; ANGIOTENSIN-II; SODIUM-INTAKE; TYPE-2; PODOCYTE;
D O I
10.1093/ndt/gfu405
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Diabetes mellitus (DM) is increasingly recognized as a heterogeneous condition. The individualization of care and treatment necessitates an understanding of the individual patient's pathophysiology of DM that underpins their DM classification and clinical presentation. Classical type-2 diabetes mellitus is due to a combination of insulin resistance and an insulin secretory defect. Type-1 diabetes is characterized by a near-absolute deficiency of insulin secretion. More recently, advances in genetics and a better appreciation of the atypical features of DM has resulted in more categories of diabetes. In the context of kidney disease, patients with DM and microalbuminuria are more insulin resistant, and insulin resistance may be a pathway that results in accelerated progression of diabetic kidney disease. This review summarizes the updated classification of DM, including more rarer categories and their associated renal manifestations that need to be considered in patients who present with atypical features. The benefits and limitations of the tests utilized to make a diagnosis of DM are discussed. We also review the putative pathways and mechanisms by which insulin resistance drives the progression of diabetic kidney disease.
引用
收藏
页码:206 / 213
页数:8
相关论文
共 50 条
  • [41] Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus
    Alsahli, Mazen
    Gerich, John E.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (11) : 1564 - 1571
  • [42] Chronic kidney disease in patients with diabetes mellitus
    Nordheim, Espen
    Jenssen, Trond Geir
    ENDOCRINE CONNECTIONS, 2021, 10 (05) : R151 - R159
  • [43] Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
    Perumalsamy, Sangeetha
    Huri, Hasniza Zaman
    Abdullah, Bashar Mudhaffar
    Mazlan, Othman
    Ahmad, Wan Azman Wan
    Vethakkan, Shireene Ratna D. B.
    METABOLITES, 2023, 13 (03)
  • [44] Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
    Gul, Ambreen
    Zager, Philip
    CURRENT DIABETES REPORTS, 2018, 18 (04)
  • [45] The relation of mTOR with diabetic complications and insulin resistance in patients with type 2 diabetes mellitus
    Amin, Noha G.
    Rahim, A. Abdel
    Rohoma, Kamel
    Elwafa, Reham A. Abo
    Dabees, Hossam M. F.
    Elrahmany, Shimaa
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01)
  • [46] Clinical Manifestations and Natural History of Diabetic Kidney Disease
    Ritz, Eberhard
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (01) : 19 - +
  • [47] The Role of Platelets in Diabetic Kidney Disease
    Rustiasari, Ukhti Jamil
    Roelofs, Joris J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [48] The Role of Mitochondria in Diabetic Kidney Disease
    Stein Hallan
    Kumar Sharma
    Current Diabetes Reports, 2016, 16
  • [49] Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease
    Thakur, Vikram
    Nargis, Syeda
    Gonzalez, Mayra
    Pradhan, Swetak
    Terreros, Daniel
    Chattopadhyay, Munmun
    NEPHRON, 2017, 137 (02) : 137 - 147
  • [50] Cardiovascular Disease and Diabetic Kidney Disease
    Maqbool, Muhammad
    Cooper, Marke.
    Jandeleit-Dahm, Karin A. M.
    SEMINARS IN NEPHROLOGY, 2018, 38 (03) : 217 - 232